---
title: Epistemic Blinding: An Inference-Time Protocol for Auditing Prior Contamination in LLM-Assisted Analysis
created: 2024-05-22
source: https://arxiv.org/abs/2604.06013
tags: [AI, Machine Learning, Drug Discovery, Auditability, Bias Mitigation]
category: ai, machine-learning, drug-discovery, technology
---

# Epistemic Blinding

## Overview
[[epistemic-blinding-an-inference-time-protocol-for-auditing-prior-contamination-i|Epistemic Blinding]] is an inference-time protocol designed to mitigate and audit **prior contamination** in [[large-language-models-for-outpatient-referral-problem-definition-benchmarking-an|Large Language Models]] (LLMs). In complex agentic workflows—such as those used for [[targeting-phgdh-for-alzheimers-disease-drug-discovery-strategies|drug discovery]] or financial screening—LLMs often blend reasoning derived from provided datasets with "parametric knowledge" (data memorized during the model's training). This blending is typically invisible, making it impossible to discern whether a model's conclusion is based on the provided evidence or merely its pre-existing training biases.

## The Problem: Prior Contamination
As LLMs are integrated into autonomous reasoning agents, a critical lack of [[auditability]] emerges. When an agent analyzes biological datasets or financial reports, its outputs may be driven by "brand recognition" or known entity associations rather than the empirical data presented in the prompt. This phenomenon, known as prior contamination, compromises the scientific integrity of automated research, as the researcher cannot verify if the agent is adhering to the intended analytical process.

## The Protocol
The epistemic blinding protocol introduces a simple yet effective layer of anonymization. Before prompting the LLM, the system performs the following steps:
1. **Anonymization**: Replaces all identifiable entity names (e.g., specific proteins, genes, or company tickers) with anonymous, arbitrary codes.
2. **Blind Inference**: The model performs reasoning across the blinded dataset.
3. **Comparative Audit**: The system compares the blinded output against an unblinded control group to measure the delta caused by entity identity.

While the protocol does not render LLM reasoning deterministic, it restores a vital dimension of transparency by quantifying the influence of the model's training memory on its conclusions.

## Empirical Findings
The efficacy of the protocol was demonstrated across two distinct domains:

*   **Biology & Oncology**: In drug target prioritization across four cancer types, blinding altered 16% of the top-20 predictions. Notably, the protocol preserved the identification of all validated targets, suggesting that the underlying biological reasoning remained robust even without entity names.
*   **Finance**: In S&P 500 equity screening, the presence of identity bias was much more pronounced, with brand recognition reshaping 30-40% of top-20 rankings.

## Implementation
To facilitate widespread adoption in [[a-comparative-analysis-of-machine-learning-models-in-shap-analysis|machine-learning]] workflows, the protocol has been released as an open-source tool and as a specialized **Claude Code skill**, enabling one-command epistemic